282 related articles for article (PubMed ID: 22251470)
1. Smad3 and its phosphoisoforms are prognostic predictors of hepatocellular carcinoma after curative hepatectomy.
Kim SH; Ahn S; Park CK
Hepatobiliary Pancreat Dis Int; 2012 Feb; 11(1):51-9. PubMed ID: 22251470
[TBL] [Abstract][Full Text] [Related]
2. Smad3 and Smad3 phosphoisoforms are prognostic markers of gastric carcinoma.
Kim SH; Kim KH; Ahn S; Hyeon J; Park CK
Dig Dis Sci; 2013 Apr; 58(4):989-97. PubMed ID: 23179147
[TBL] [Abstract][Full Text] [Related]
3. Notch1 and Notch4 are markers for poor prognosis of hepatocellular carcinoma.
Ahn S; Hyeon J; Park CK
Hepatobiliary Pancreat Dis Int; 2013 Jun; 12(3):286-94. PubMed ID: 23742774
[TBL] [Abstract][Full Text] [Related]
4. Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
Murata M; Matsuzaki K; Yoshida K; Sekimoto G; Tahashi Y; Mori S; Uemura Y; Sakaida N; Fujisawa J; Seki T; Kobayashi K; Yokote K; Koike K; Okazaki K
Hepatology; 2009 Apr; 49(4):1203-17. PubMed ID: 19263472
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance and relationship of SMAD3 phospho-isoforms and VEGFR-1 in gastric cancer: A clinicopathological study.
Lv SL; Guo P; Zou JR; Chen RS; Luo LY; Huang DQ
World J Gastrointest Oncol; 2024 Jan; 16(1):118-132. PubMed ID: 38292835
[TBL] [Abstract][Full Text] [Related]
6. Chronic inflammation associated with hepatitis C virus infection perturbs hepatic transforming growth factor beta signaling, promoting cirrhosis and hepatocellular carcinoma.
Matsuzaki K; Murata M; Yoshida K; Sekimoto G; Uemura Y; Sakaida N; Kaibori M; Kamiyama Y; Nishizawa M; Fujisawa J; Okazaki K; Seki T
Hepatology; 2007 Jul; 46(1):48-57. PubMed ID: 17596875
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of Smad3, Smad4, Smad3 phosphoisoform expression in esophageal squamous cell carcinoma.
Cho SY; Ha SY; Huang SM; Kim JH; Kang MS; Yoo HY; Kim HH; Park CK; Um SH; Kim KH; Kim SH
Med Oncol; 2014 Nov; 31(11):236. PubMed ID: 25267569
[TBL] [Abstract][Full Text] [Related]
8. Smad3 phosphoisoform-mediated signaling during sporadic human colorectal carcinogenesis.
Matsuzaki K
Histol Histopathol; 2006 Jun; 21(6):645-62. PubMed ID: 16528675
[TBL] [Abstract][Full Text] [Related]
9. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21(WAF1) pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells.
Li Q; Liu G; Yuan H; Wang J; Guo Y; Chen T; Zhai R; Shao D; Ni W; Tai G
Oncotarget; 2015 Feb; 6(6):4253-65. PubMed ID: 25714018
[TBL] [Abstract][Full Text] [Related]
10. IL-37 suppresses hepatocellular carcinoma growth by converting pSmad3 signaling from JNK/pSmad3L/c-Myc oncogenic signaling to pSmad3C/P21 tumor-suppressive signaling.
Liu R; Tang C; Shen A; Luo H; Wei X; Zheng D; Sun C; Li Z; Zhu D; Li T; Wu Z
Oncotarget; 2016 Dec; 7(51):85079-85096. PubMed ID: 27835881
[TBL] [Abstract][Full Text] [Related]
11. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
[TBL] [Abstract][Full Text] [Related]
12. High level of intercellular adhesion molecule-1 affects prognosis of patients with hepatocellular carcinoma.
Zhu PP; Yuan SG; Liao Y; Qin LL; Liao WJ
World J Gastroenterol; 2015 Jun; 21(23):7254-63. PubMed ID: 26109813
[TBL] [Abstract][Full Text] [Related]
13. Expression of prothymosin alpha predicts early recurrence and poor prognosis of hepatocellular carcinoma.
Ha SY; Song DH; Hwang SH; Cho SY; Park CK
Hepatobiliary Pancreat Dis Int; 2015 Apr; 14(2):171-7. PubMed ID: 25865690
[TBL] [Abstract][Full Text] [Related]
14. Role of phosphorylated Smad3 signal components in intraductal papillary mucinous neoplasm of pancreas.
Hori Y; Ikeura T; Yamaguchi T; Yoshida K; Matsuzaki K; Ishida M; Satoi S; Okazaki K
Hepatobiliary Pancreat Dis Int; 2020 Dec; 19(6):581-589. PubMed ID: 32532597
[TBL] [Abstract][Full Text] [Related]
15. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.
Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
Dig Dis Sci; 2013 Jul; 58(7):1916-22. PubMed ID: 23456506
[TBL] [Abstract][Full Text] [Related]
16. Oncogenic Smad3 signaling induced by chronic inflammation is an early event in ulcerative colitis-associated carcinogenesis.
Kawamata S; Matsuzaki K; Murata M; Seki T; Matsuoka K; Iwao Y; Hibi T; Okazaki K
Inflamm Bowel Dis; 2011 Mar; 17(3):683-95. PubMed ID: 20602465
[TBL] [Abstract][Full Text] [Related]
17. [A new prognostic score system of hepatocellular carcinoma following hepatectomy].
Wang YK; Bi XY; Li ZY; Zhao H; Zhao JJ; Zhou JG; Huang Z; Zhang YF; Li MX; Chen X; Wu XL; Mao R; Hu XH; Hu HJ; Liu JM; Cai JQ
Zhonghua Zhong Liu Za Zhi; 2017 Dec; 39(12):903-909. PubMed ID: 29262506
[No Abstract] [Full Text] [Related]
18. Smad Phospho-Isoforms for Hepatocellular Carcinoma Risk Assessment in Patients with Nonalcoholic Steatohepatitis.
Suwa K; Yamaguchi T; Yoshida K; Murata M; Ichimura M; Tsuneyama K; Seki T; Okazaki K
Cancers (Basel); 2020 Jan; 12(2):. PubMed ID: 31991602
[TBL] [Abstract][Full Text] [Related]
19. Post-hepatectomy survival in advanced hepatocellular carcinoma with portal vein tumor thrombosis.
Yamamoto Y; Ikoma H; Morimura R; Shoda K; Konishi H; Murayama Y; Komatsu S; Shiozaki A; Kuriu Y; Kubota T; Nakanishi M; Ichikawa D; Fujiwara H; Okamoto K; Sakakura C; Ochiai T; Otsuji E
World J Gastroenterol; 2015 Jan; 21(1):246-53. PubMed ID: 25574098
[TBL] [Abstract][Full Text] [Related]
20. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]